000 01514 a2200469 4500
005 20250518043905.0
264 0 _c20210310
008 202103s 0 0 eng d
022 _a2013-2514
024 7 _a10.1016/j.nefro.2019.03.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorrego Utiel, Francisco José
245 0 0 _aUrinary osmolality in patients with polycystic kidney disease: Measured or calculated?
_h[electronic resource]
260 _bNefrologia
_c
300 _a202-204 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntidiuretic Hormone Receptor Antagonists
_xtherapeutic use
650 0 4 _aCalcium
_xurine
650 0 4 _aCreatinine
_xurine
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOsmolar Concentration
650 0 4 _aPolycystic Kidney, Autosomal Dominant
_xurine
650 0 4 _aPotassium
_xurine
650 0 4 _aReceptors, Vasopressin
_xdrug effects
650 0 4 _aSodium
_xurine
650 0 4 _aTolvaptan
_xtherapeutic use
650 0 4 _aUrea
_xurine
650 0 4 _aUric Acid
_xurine
650 0 4 _aUrine
_xchemistry
650 0 4 _aYoung Adult
700 1 _aCamacho Reina, María Victoria
700 1 _aMoriana Domínguez, Clara
700 1 _aMerino García, Enoc
773 0 _tNefrologia
_gvol. 40
_gno. 2
_gp. 202-204
856 4 0 _uhttps://doi.org/10.1016/j.nefro.2019.03.010
_zAvailable from publisher's website
999 _c29795933
_d29795933